Group 1 - Pomerantz LLP is investigating claims on behalf of investors of Duluth Holdings Inc. regarding potential securities fraud or unlawful business practices by the company and its officers/directors [1] - On December 16, 2025, Duluth announced a reduction in its net sales guidance to a range of $555 million to $565 million, down from the previous guidance of $570 million to $595 million [3] - Following the announcement of lowered sales guidance, Duluth's stock price fell by $0.92 per share, or 29.39%, closing at $2.21 per share on the same day [3] Group 2 - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of fighting for the rights of victims of securities fraud and corporate misconduct [4]

Core Viewpoint - The Portnoy Law Firm has initiated an investigation into Bgin Blockchain Limited for possible securities fraud and may file a class action on behalf of investors [1]. Group 1: Company Financial Performance - Bgin Blockchain Limited completed its Initial Public Offering (IPO) on October 21, 2025 [2]. - The company reported a significant decline in total revenue, which decreased by approximately $96 million compared to the previous year [3]. - Operating expenses surged by 582.8%, leading to a gross loss of $6.3 million, a stark contrast to the gross profit of $84.8 million reported in the prior year [3]. - As of December 29, 2025, Bgin's shares traded as low as $2.45, marking a decline of $3.55 or 59% from the IPO price of $6.00 per share [3]. Group 2: Corporate Governance Changes - On December 5, 2025, Bgin announced the termination of its Chief Communications Officer on a mutual amicable basis [3]. - The company decided not to renew or negotiate new terms with its current auditor and approved the engagement of a new independent registered public accounting firm effective December 12, 2025 [3].

SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is I ...

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - Alexandria Real Estate reported lower-than-expected results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on consecutive days [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. Legal Proceedings - Investors have until January 26, 2026, to request to lead the case in the U.S. District Court for the Central District of California, under the caption Hern v. Alexandria Real Estate Equities, Inc., et al. [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3].

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. and its senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Stride, Inc. is an education technology company that provides an online platform for students across the U.S. [4]. Allegations and Stock Impact - The lawsuit alleges that Stride inflated enrollment numbers by retaining "ghost students," ignored compliance requirements, and had a poor customer experience leading to higher withdrawal rates and lower conversion rates [4]. - On September 14, 2025, a report of fraud allegations caused Stride's stock to drop by $18.60 per share, over 11%, from $158.36 to $139.76 [5]. - On October 28, 2025, Stride admitted to poor customer experience affecting enrollments, leading to a further stock drop of $83.48 per share, over 54%, from $153.53 to $70.05 [6]. Legal Proceedings - Investors have until January 12, 2026, to request to lead the case in the U.S. District Court for the Eastern District of Virginia [3]. - The lawsuit is titled MacMahon v. Stride, Inc., et al., No. 1:25-cv-02019 [3]. Legal Representation - Bleichmar Fonti & Auld LLP is representing the plaintiffs in this class action and has a history of successful recoveries in securities class actions [8].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and certain senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations of Securities Fraud - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had reportedly fallen sharply, contradicting the company's public statements about sales growth and market position [4][5]. Stock Price Decline - On October 23, 2025, Integer revised its 2025 sales guidance down to between $1.840 billion and $1.854 billion, significantly below analysts' expectations. The company also projected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. This announcement led to a stock price drop of $35.22 per share, or over 32%, from $109.11 to $73.89 [6].

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Minnesota, titled City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., et al., No. 0:25-cv-04247 [3]. - Investors have until January 5, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Inspire Medical Systems develops and manufactures an implantable medical device for treating sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [4]. Group 3: Allegations Against Inspire - The complaint alleges that Inspire misled investors by claiming it had taken necessary steps for the launch of Inspire V, while in reality, it failed to prepare clinicians and payors, leading to delays in adoption [5][6]. - The company faced weak demand for Inspire V due to customers having excess inventory of older devices [6]. Group 4: Stock Price Impact - On August 4, 2025, Inspire disclosed that the launch of Inspire V would take longer than expected, resulting in a reduction of its 2025 earnings per share guidance by over 80% [7]. - The stock price dropped by $42.04 per share, or more than 32%, from $129.95 on August 4, 2025, to $87.91 on August 5, 2025 [8].

Core Viewpoint - The article discusses a class action lawsuit against StubHub Holdings, Inc. related to its initial public offering (IPO) on September 17, 2025, alleging violations of the Securities Act of 1933 due to misleading financial disclosures [1][3]. Group 1: Class Action Lawsuit Details - The class action lawsuit, titled Salabaj v. StubHub Holdings, Inc., claims that StubHub's IPO offering documents were materially false and misleading, particularly regarding changes in payment timing to vendors that adversely affected free cash flow [3][4]. - StubHub's IPO involved the issuance of approximately 34 million shares at an offering price of $23.50 per share [2]. - Following the release of disappointing financial results on November 13, 2025, which included a free cash flow of negative $4.6 million (a 143% decrease) and a net cash from operating activities of $3.8 million (a 69.3% decrease), StubHub's stock price fell nearly 21% [3]. Group 2: Stock Performance - By the time the class action lawsuit commenced, StubHub's stock price had dropped to as low as $10.31 per share, representing a nearly 56% decline from the IPO price of $23.50 [4]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased StubHub common stock in connection with the IPO to seek appointment as lead plaintiff in the class action lawsuit [5]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and acts on behalf of all class members [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6].

Core Viewpoint - A class action lawsuit has been filed against Fiserv, Inc. on behalf of investors who purchased shares during the specified class period, alleging misleading statements regarding the company's guidance and performance [1][3]. Group 1: Lawsuit Details - The lawsuit claims that Fiserv revised its 2025 guidance in July 2025, indicating that while some initiatives were delayed, they were fundamentally sound [3]. - On October 29, 2025, Fiserv admitted that its July guidance was based on assumptions that were difficult to achieve, leading to a significant drop in share value [3]. - Following the acknowledgment of these misleading statements, Fiserv's shares fell by 44% in one day, from $126.17 on October 28, 2025, to $70.60 on October 29, 2025 [3]. Group 2: Investor Information - Investors who purchased Fiserv securities during the class period have until January 5, 2026, to seek appointment as lead plaintiff representatives [2]. - The law firm Berger Montague is handling the case and provides contact information for interested investors [4]. Group 3: Company Background - Fiserv is a global payments and financial technology company headquartered in Milwaukee, Wisconsin [2]. - Berger Montague, the law firm involved, is recognized for its expertise in complex civil litigation and has recovered over $50 billion for clients over its 55-year history [4].

Group 1 - Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. regarding potential securities fraud or unlawful business practices by the company and its officers/directors [1] - On December 15, 2025, SNDL announced an amendment to its agreement to acquire 32 cannabis retail stores from 1CM, maintaining a total purchase price of $32.2 million in cash, but splitting the acquisition into two closings for regulatory approval [2] - Following the announcement of the amended acquisition agreement, SNDL's stock price fell by $0.29 per share, or 13.12%, closing at $1.92 per share on December 15, 2025 [3]